| Patent application number | Description | Published |
|---|
| 20080199446 | Uronic Acid and Probiotics - The present invention relates to compositions containing probiotic bacteria and uronic acid oligosaccharides. The compositions can suitably be used as infant nutrition and advantageously reduce the incidence of infection. | 08-21-2008 |
| 20090156550 | COMPOSITION CONTAINING OLIGOSACCHARIDES FOR THE TREATMENT/PREVENTION OF INFECTIONS - The present invention relates to the use of oligosaccharide mixtures for the treatment and/or prevention of infections, in particular for reducing the severity of childhood infection or the treatment and/or prevention of childhood infection. | 06-18-2009 |
| 20090220639 | PREVENTING DISEASES IN INFANTS DELIVERED VIA CAESAREAN SECTION - The present invention provides the use of a composition comprising non-digestible oligosaccharide for the manufacture of a composition for enteral administration to an infant delivered via caesarean section. | 09-03-2009 |
| 20090305996 | USE OF NON-DIGESTABLE SACHARIDES FOR GIVING AN INFANT THE BEST START AFTER BIRTH - A food or supplement for pregnant women comprising water soluble, non-digestible saccharides is described. The composition is used to improve the flora and/or immune system of the pregnant women, to improve the immune system of the infant and to improve the intestinal flora of the infant after birth. | 12-10-2009 |
| 20100035828 | MILK OLIGOSACCHARIDE FOR STIMULATING THE IMMUNE SYSTEM - The present invention relates to methods and nutritional compositions for stimulating the immune system, particularly in subjects with an impaired immune system such as 5 infants, said method comprising administering a composition comprising sheep milk and/or short chain oligosaccharides. | 02-11-2010 |
| 20100063002 | METHOD OF IMPROVING SKILLS WITH A COMPOSITION COMPRISING NON-DIGESTIBLE SACCHARIDE - The present invention concerns a therapy aimed at language and/or social skills in infants through administration of components stimulating the development of a healthy intestinal flora. | 03-11-2010 |
| 20100167982 | BARRIER INTEGRITY IN HIV PATIENTS - The invention concerns a method for stimulating intestinal barrier integrity in a patient infected with HIV by administering to said patient composition comprising: eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA) and arachidonic acid (ARA), and at least two distinct oligosaccharides. | 07-01-2010 |
| 20100216740 | Cereal-based Infant Nutrition with Fibre - Cereal-based semi-liquid and/or semi-solid compositions suitable for supporting the transition period wherein the infant changes from a diet consisting of breast milk or liquid infant formula to solid adult foods, comprising uronic acid carbohydrates with a degree of polymerisation (DP) between 10 and 300 and also uses thereof are disclosed. | 08-26-2010 |
| 20100234286 | PRETERM FORMULA - The present invention relates to a method and a composition for feeding low birthweight infants (LBW infants), very low birthweight infants (VLBW infants), extremely low birthweight infants (ELBW infants) and preterm infants for improving oral tolerance. | 09-16-2010 |
| 20100330040 | COMPOSITION WITH SYNBIOTICS - Nutritional compositions with health benefits comprising bacterial strains and galactooligosaccharides are disclosed. | 12-30-2010 |
| 20110117077 | NUTRITIONAL COMPOSITION FOR INFANTS DELIVERED VIA CAESAREAN SECTION - The present invention relates to methods for feeding of infants delivered via caesarean section and to compositions to be administered to infants delivered via caesarean section and in particular to the use of a product obtained by fermentation of milk, whey, whey protein, whey protein hydrolysate, casein, casein hydrolysate and/or lactose by lactic acid producing bacteria. Thereby it is possible to stimulate a fast colonisation of the intestinal microbiota of said infants. | 05-19-2011 |
| 20110150851 | NUTRITIONAL COMPOSITION FOR INFANTS DELIVERED VIA CAESAREAN SECTION - The present invention relates to compositions to be administered to infants delivered via caesarean section and in particular to a product comprising inactivated cells and/or bacterial cell fragments of Gram-negative bacteria and of optionally inactivated Gram-positive bacteria. Thereby it is possible to stimulate a fast colonisation of the intestinal microbiota of said infants. | 06-23-2011 |
